MARKET

BJDX

BJDX

Bluejay Diagnostics Inc
NASDAQ
1.960
-0.020
-1.01%
After Hours: 1.850 -0.11 -5.61% 16:09 03/27 EDT
OPEN
1.976
PREV CLOSE
1.980
HIGH
1.976
LOW
1.830
VOLUME
7.89K
TURNOVER
--
52 WEEK HIGH
40.80
52 WEEK LOW
1.700
MARKET CAP
2.03M
P/E (TTM)
-0.0321
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BJDX last week (0316-0320)?
Weekly Report · 5d ago
Bluejay Diagnostics Announces Insider-Funded Private Stock Placement
TipRanks · 03/17 22:05
Bluejay Diagnostics sells 62,500 shares in private placement for USD 125,000
Reuters · 03/17 21:30
Bluejay Weighs Proposed Therapeutic Acquisition, Reaffirms Symphony Focus
TipRanks · 03/16 10:29
Weekly Report: what happened at BJDX last week (0309-0313)?
Weekly Report · 03/16 09:59
Bluejay Advances Symphony IL-6 Sepsis Diagnostic Program
TipRanks · 03/12 16:44
Bluejay Diagnostics’ Symphony IL-6 sepsis study accepted for SAEM annual meeting presentation
Reuters · 03/12 10:30
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
Barchart · 03/12 05:30
More
About BJDX
Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes in critical care settings. It develops rapid tests using whole blood on its Symphony technology platform (Symphony), which consists of an analyzer and single-use protein detection cartridges that have the function of automatic stepwise feeding of reagent. The Symphony device is designed to produce laboratory-quality results in 20 minutes in critical care settings, including Intensive Care Units (ICUs) and Emergency Rooms (ERs). Its product candidate, the Symphony IL-6 test, is an immunoassay for the measurement of interleukin-6 (IL-6) to be used for the monitoring of disease progression in critical care settings. It is focused on pursuing the Symphony IL-6 test in the context of sepsis. IL-6 is a clinically established inflammatory biomarker, and is considered a 'first-responder', for the assessment of severity of infection and inflammation across many disease indications, including sepsis.

Webull offers Bluejay Diagnostics Inc stock information, including NASDAQ: BJDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BJDX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BJDX stock methods without spending real money on the virtual paper trading platform.